Bas W.G. van Rhijn

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate.

Bas W.G. van Rhijn, Irene Lurkin, François Radvanyi et al. · PubMed · 2001 · 309 citations

Tumor Biology, Surgical Oncology, Urology +15

Penile Sparing Surgery for Penile Cancer—Does it Affect Survival?

Rosa S. Djajadiningrat, Erik van Werkhoven, Wim Meinhardt et al. · The Journal of Urology · 2013 · 137 citations

Urology, Surgical Oncology, Genitourinary Cancer +12

Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer

Roman Mayr, Michael Gierth, Florian Zeman et al. · Journal of Cachexia Sarcopenia and Muscle · 2018 · 128 citations · Full text

Radical Cystectomy, Surgical Oncology, Cancer Management +16

Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis

Joep J. de Jong, Yang Liu, A. Gordon Robertson et al. · Genome Medicine · 2019 · 89 citations · Full text

Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer

Roman Mayr, Hans‐Martin Fritsche, Florian Zeman et al. · World Journal of Urology · 2018 · 87 citations

Radical Cystectomy, Urology, Surgical Oncology +7